Cargando…

A Review of Biomarkers and Their Clinical Impact in Resected Early-Stage Non-Small-Cell Lung Cancer

SIMPLE SUMMARY: Non-small-cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancers, and the postoperative survival of early-stage NSCLC patients remains unsatisfactory. Over the last several decades, mutant genes, immunological checkpoints, and blood-based biomarkers have been dev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Weibo, Tang, Quanying, Zeng, Jingtong, Jin, Xin, Zu, Lingling, Xu, Song
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526902/ https://www.ncbi.nlm.nih.gov/pubmed/37760531 http://dx.doi.org/10.3390/cancers15184561

Ejemplares similares

Clinical significance of preoperative neutrophil‐lymphocyte ratio and platelet‐lymphocyte ratio in the prognosis of resected early‐stage patients with non‐small cell lung cancer: A meta‐analysis
por: Cao, Weibo, et al.
Publicado: (2022)

The Profile and Clinical Significance of ITGB2 Expression in Non-Small-Cell Lung Cancer
por: Zu, Lingling, et al.
Publicado: (2022)

Lobe‐specific analysis of perioperative chemotherapy for non‐small cell lung cancer patients
por: Lei, Xi, et al.
Publicado: (2023)

Identification of a novel oxidative stress-related prognostic model in lung adenocarcinoma
por: Zhu, Yifan, et al.
Publicado: (2022)

Use of savolitinib as neoadjuvant therapy for non–small cell lung cancer patient with MET exon 14 skipping alterations: A case report
por: Zhang, Yu, et al.
Publicado: (2022)

Analysis of Molecular Biomarkers in Resected Early-Stage Non-Small Cells Lung Cancer: A Narrative Review
por: Gallina, Filippo Tommaso, et al.
Publicado: (2022)

Characteristics of the immune microenvironment and their clinical significance in non-small cell lung cancer patients with ALK-rearranged mutation
por: Zhang, Bo, et al.
Publicado: (2022)

Multidisciplinary Management of Resectable Early-Stage Non–Small Cell Lung Cancer
por: Jacky, Jennifer, et al.
Publicado: (2022)

Adjuvant immunotherapy in early-stage resectable non–small cell lung cancer: A new milestone
por: Tang, Wen-Fang, et al.
Publicado: (2023)

Circulating and tissue biomarkers in early-stage non-small cell lung cancer
por: Fumagalli, Caterina, et al.
Publicado: (2017)

Biomarkers predictive value in early stage non-small cell lung cancer
por: Malapelle, Umberto, et al.
Publicado: (2020)

Prognosis of Recurrence after Complete Resection in Early-Stage Non-Small Cell Lung Cancer
por: Choi, Pil Jo, et al.
Publicado: (2013)

Sublobar resection in the treatment of elderly patients with early-stage non-small cell lung cancer
por: Afonso, Margarida, et al.
Publicado: (2020)

Wedge resection—finding its place in early-stage non-small cell lung cancer?
por: Hill, Morgan A., et al.
Publicado: (2023)

Predictors of Recurrence after Curative Resection in Patients with Early-Stage Non-Small Cell Lung Cancer
por: Lee, Sang Hee, et al.
Publicado: (2015)

Programmed death ligand 1 expression in early stage, resectable non-small cell lung cancer
por: D’Arcangelo, Manolo, et al.
Publicado: (2019)

Metabolic Changes in Early-Stage Non–Small Cell Lung Cancer Patients after Surgical Resection
por: Ahmed, Naseer, et al.
Publicado: (2021)

Risk factors of brain metastases in completely resected pathological stage IIIA-N2 non-small cell lung cancer
por: Ding, Xiao, et al.
Publicado: (2012)

Neoadjuvant chemoimmunotherapy in resectable stage IIIA/IIIB non-small cell lung cancer
por: Chen, Yulong, et al.
Publicado: (2021)

Selection of proper candidates with resected pathological stage IIIA-N2 non-small cell lung cancer for postoperative radiotherapy
por: Hui, Zhouguang, et al.
Publicado: (2015)

Survival rates after lobectomy versus sublobar resection for early‐stage right middle lobe non‐small cell lung cancer
por: Lv, Xiayi, et al.
Publicado: (2018)

Establishment of a biomarker model for predicting bone metastasis in resected stage III non-small cell lung cancer
por: Zhou, Zhen, et al.
Publicado: (2012)

Idiopathic Pulmonary Fibrosis in Patients with Early-stage Non-small-cell Lung Cancer after Surgical Resection
por: Nezka, Hribernik, et al.
Publicado: (2019)

Economic burden of locoregional and metastatic relapses in resectable early-stage non-small cell lung cancer in Spain
por: De Castro, Javier, et al.
Publicado: (2023)

Biomarkers of immunotherapy in non-small cell lung cancer
por: Wang, Lingling, et al.
Publicado: (2020)

Comprehensive analyses of one-carbon metabolism related genes and their association with prognosis, tumor microenvironment, chemotherapy resistance and immunotherapy in lung adenocarcinoma
por: Zhou, Ning, et al.
Publicado: (2022)

Resection of Early-Stage Second Primary Non-small Cell Lung Cancer After Small Cell Lung Cancer: A Population-Based Study
por: Zhang, Rusi, et al.
Publicado: (2020)

Neutrophil–lymphocyte ratio is prognostic in early stage resected small-cell lung cancer
por: Lohinai, Zoltan, et al.
Publicado: (2019)

Recurrence risk after preoperative biopsy in patients with resected early-stage non-small-cell lung cancer: a retrospective study
por: Hu, Chengping, et al.
Publicado: (2018)

The Impact of Programmed Death-Ligand 1 Expression on the Prognosis of Early Stage Resected Non-Small Cell Lung Cancer: A Meta-Analysis of Literatures
por: Shi, Tao, et al.
Publicado: (2021)

CDCP1 Expression Is a Potential Biomarker of Poor Prognosis in Resected Stage I Non-Small-Cell Lung Cancer
por: Nam, Yunha, et al.
Publicado: (2022)

Analysis of middle- and long-term efficacy of thoracoscope-assisted segmental resection of the lung on non-small cell lung cancer in the early stage
por: Ding, Ning, et al.
Publicado: (2018)

Preoperative splenic area as a prognostic biomarker of early-stage non-small cell lung cancer
por: Liu, Mengmei, et al.
Publicado: (2023)

Lobectomy versus sublobar resection for stage I (T1‐T2aN0M0) small cell lung cancer: A SEER population‐based propensity score matching analysis
por: Zhou, Ning, et al.
Publicado: (2022)

Meta-analysis of segmentectomy versus wedge resection in stage IA non-small-cell lung cancer
por: Xue, Wenfei, et al.
Publicado: (2018)

Clinical outcomes of stereotactic body radiotherapy for de novo pulmonary tumors in patients with completely resected early stage non-small cell lung cancer
por: Zhao, Qianqian, et al.
Publicado: (2018)

Wedge Resection and Segmentectomy in Patients with Stage I Non-Small Cell Lung Carcinoma
por: Reveliotis, Konstantinos, et al.
Publicado: (2014)

Impact of Sarcopenia on Early Postoperative Complications in Early-Stage Non–Small-Cell Lung Cancer
por: Lee, Jiyun, et al.
Publicado: (2020)

Progress on neoadjuvant immunotherapy in resectable non-small cell lung cancer and potential biomarkers
por: Wu, Xinyu, et al.
Publicado: (2023)

Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer
por: Geng, Qing, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_uasrdonaqevnqmqstrtpsqg7a6